Eosinophil CD48 interactions with Candida albicans Als6 is protective in vitro and in mouse systemic candidiasis.
Saved in:
| Title: | Eosinophil CD48 interactions with Candida albicans Als6 is protective in vitro and in mouse systemic candidiasis. |
|---|---|
| Authors: | Zaffran I; Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Institute for Drug Research, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Gaur P; Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Institute for Drug Research, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Ofori P; Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Institute for Drug Research, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Charpak-Amikam Y; The Concern Foundation Laboratories at the Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel-Canada (IMRIC), Hebrew University Medical School, Jerusalem, Israel., Pahima H; Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Institute for Drug Research, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Shasha D; Infectious Diseases Unit, Tel Aviv Sourasky Medical Center; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Osherov N; Department of Clinical Microbiology and Immunology Gray School of Medical Sciences, Tel-Aviv University, Tel-Aviv, Israel., Hube B; Department of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute, Jena, Germany.; Institute of Microbiology, Friedrich Schiller University, Jena, Germany., Ben-Ami R; Infectious Diseases Unit, Tel Aviv Sourasky Medical Center; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Naglik JR; Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, London, UK., Mandelboim O; The Concern Foundation Laboratories at the Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel-Canada (IMRIC), Hebrew University Medical School, Jerusalem, Israel., Vitte J; Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Institute for Drug Research, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.; INSERM UMR-S 1250 P3CELL and Laboratory of Immunology, Faculty of Medicine; University Hospital of Reims, University of Reims, Champagne-Ardenne, Reims, France.; Montpellier University, Institut Desbrest d'Épidémiologie et de Santé Publique, Institut National de la Sante et de la Recherche Medicale, UMR UA 11, Montpellier, France., Levi-Schaffer F; Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Institute for Drug Research, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. francescal@ekmd.huji.ac.il. |
| Source: | Nature communications [Nat Commun] 2025 Oct 21; Vol. 16 (1), pp. 9291. Date of Electronic Publication: 2025 Oct 21. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41120328 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Eosinophil CD48 interactions with Candida albicans Als6 is protective in vitro and in mouse systemic candidiasis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zaffran+I%22">Zaffran I</searchLink>; Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Institute for Drug Research, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Gaur+P%22">Gaur P</searchLink>; Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Institute for Drug Research, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Ofori+P%22">Ofori P</searchLink>; Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Institute for Drug Research, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Charpak-Amikam+Y%22">Charpak-Amikam Y</searchLink>; The Concern Foundation Laboratories at the Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel-Canada (IMRIC), Hebrew University Medical School, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Pahima+H%22">Pahima H</searchLink>; Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Institute for Drug Research, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Shasha+D%22">Shasha D</searchLink>; Infectious Diseases Unit, Tel Aviv Sourasky Medical Center; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Osherov+N%22">Osherov N</searchLink>; Department of Clinical Microbiology and Immunology Gray School of Medical Sciences, Tel-Aviv University, Tel-Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Hube+B%22">Hube B</searchLink>; Department of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute, Jena, Germany.; Institute of Microbiology, Friedrich Schiller University, Jena, Germany.<br /><searchLink fieldCode="AU" term="%22Ben-Ami+R%22">Ben-Ami R</searchLink>; Infectious Diseases Unit, Tel Aviv Sourasky Medical Center; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Naglik+JR%22">Naglik JR</searchLink>; Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Mandelboim+O%22">Mandelboim O</searchLink>; The Concern Foundation Laboratories at the Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel-Canada (IMRIC), Hebrew University Medical School, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Vitte+J%22">Vitte J</searchLink>; Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Institute for Drug Research, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.; INSERM UMR-S 1250 P3CELL and Laboratory of Immunology, Faculty of Medicine; University Hospital of Reims, University of Reims, Champagne-Ardenne, Reims, France.; Montpellier University, Institut Desbrest d'Épidémiologie et de Santé Publique, Institut National de la Sante et de la Recherche Medicale, UMR UA 11, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Levi-Schaffer+F%22">Levi-Schaffer F</searchLink>; Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Institute for Drug Research, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. francescal@ekmd.huji.ac.il. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2025 Oct 21; Vol. 16 (1), pp. 9291. <i>Date of Electronic Publication: </i>2025 Oct 21. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41120328 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-025-64276-3 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 9291 Titles: – TitleFull: Eosinophil CD48 interactions with Candida albicans Als6 is protective in vitro and in mouse systemic candidiasis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zaffran I – PersonEntity: Name: NameFull: Gaur P – PersonEntity: Name: NameFull: Ofori P – PersonEntity: Name: NameFull: Charpak-Amikam Y – PersonEntity: Name: NameFull: Pahima H – PersonEntity: Name: NameFull: Shasha D – PersonEntity: Name: NameFull: Osherov N – PersonEntity: Name: NameFull: Hube B – PersonEntity: Name: NameFull: Ben-Ami R – PersonEntity: Name: NameFull: Naglik JR – PersonEntity: Name: NameFull: Mandelboim O – PersonEntity: Name: NameFull: Vitte J – PersonEntity: Name: NameFull: Levi-Schaffer F IsPartOfRelationships: – BibEntity: Dates: – D: 21 M: 10 Text: 2025 Oct 21 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 16 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |